318 related articles for article (PubMed ID: 25634102)
1. Catabolic metabolism during cancer EMT.
Cha YH; Yook JI; Kim HS; Kim NH
Arch Pharm Res; 2015 Mar; 38(3):313-20. PubMed ID: 25634102
[TBL] [Abstract][Full Text] [Related]
2. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation.
Li L; Li W
Pharmacol Ther; 2015 Jun; 150():33-46. PubMed ID: 25595324
[TBL] [Abstract][Full Text] [Related]
6. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
[TBL] [Abstract][Full Text] [Related]
7. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
Kim NH; Cha YH; Lee J; Lee SH; Yang JH; Yun JS; Cho ES; Zhang X; Nam M; Kim N; Yuk YS; Cha SY; Lee Y; Ryu JK; Park S; Cheong JH; Kang SW; Kim SY; Hwang GS; Yook JI; Kim HS
Nat Commun; 2017 Feb; 8():14374. PubMed ID: 28176759
[TBL] [Abstract][Full Text] [Related]
8. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
10. TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer.
Hua W; Ten Dijke P; Kostidis S; Giera M; Hornsveld M
Cell Mol Life Sci; 2020 Jun; 77(11):2103-2123. PubMed ID: 31822964
[TBL] [Abstract][Full Text] [Related]
11. Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.
Martinez-Outschoorn UE; Pestell RG; Howell A; Tykocinski ML; Nagajyothi F; Machado FS; Tanowitz HB; Sotgia F; Lisanti MP
Cell Cycle; 2011 Dec; 10(24):4208-16. PubMed ID: 22033146
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria: The ketogenic diet--A metabolism-based therapy.
Vidali S; Aminzadeh S; Lambert B; Rutherford T; Sperl W; Kofler B; Feichtinger RG
Int J Biochem Cell Biol; 2015 Jun; 63():55-9. PubMed ID: 25666556
[TBL] [Abstract][Full Text] [Related]
13. The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival.
De Oliveira MP; Liesa M
Cells; 2020 Dec; 9(12):. PubMed ID: 33291682
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
Li J; Huang Q; Long X; Guo X; Sun X; Jin X; Li Z; Ren T; Yuan P; Huang X; Zhang H; Xing J
Oncogene; 2017 Aug; 36(34):4901-4912. PubMed ID: 28436948
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism.
Cho ES; Kim NH; Yun JS; Cho SB; Kim HS; Yook JI
Cells; 2020 Sep; 9(9):. PubMed ID: 32927665
[TBL] [Abstract][Full Text] [Related]
16. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer.
Jia D; Park JH; Kaur H; Jung KH; Yang S; Tripathi S; Galbraith M; Deng Y; Jolly MK; Kaipparettu BA; Onuchic JN; Levine H
Br J Cancer; 2021 Jun; 124(12):1902-1911. PubMed ID: 33859341
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype.
Cervantes-Arias A; Pang LY; Argyle DJ
Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947
[TBL] [Abstract][Full Text] [Related]
18. Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition.
Chen XL; Lei L; Hong LL; Ling ZQ
Histol Histopathol; 2018 Jul; 33(7):655-663. PubMed ID: 29285747
[TBL] [Abstract][Full Text] [Related]
19. Including the mitochondrial metabolism of L-lactate in cancer metabolic reprogramming.
de Bari L; Atlante A
Cell Mol Life Sci; 2018 Aug; 75(15):2763-2776. PubMed ID: 29728715
[TBL] [Abstract][Full Text] [Related]
20. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.
Lunt SY; Vander Heiden MG
Annu Rev Cell Dev Biol; 2011; 27():441-64. PubMed ID: 21985671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
